SRC inhibition enables formation of a growth suppressive MAGI1-PP2A complex in isocitrate dehydrogenase-mutant cholangiocarcinoma

Iris Sze Ue Luk(Fred Hutch Cancer Center), Sita Kugel(Cape Town HVTN Immunology Laboratory / Hutchinson Centre Research Institute of South Africa), Wilhelm Haas(Harvard University), Myriam Boukhali(Harvard University), Angela Yu(Fred Hutch Cancer Center), Liberalis Debraj Boila(Fred Hutch Cancer Center), Caroline M. Bridgwater(Fred Hutch Cancer Center), Naomi Yamamoto(University of Washington), Supriya K. Saha(University of California, Los Angeles), Meena Kathiresan(Harvard University Press), Heidi L. Kenerson(University of Washington), Tian V. Tian(Vall d'Hebron Institut de Recerca), Mariana Yáñez-Bartolomé(Vall d'Hebron Institut de Recerca), Taylor S. Hulahan(Fred Hutch Cancer Center), Jonathan A. Cooper(Fred Hutch Cancer Center), Raymond S. Yeung(University of Washington), Aaron Lampano(Fred Hutch Cancer Center), Teresa Macarulla(Centro de Investigación Biomédica en Red de Cáncer), Lucas B. Sullivan(Cape Town HVTN Immunology Laboratory / Hutchinson Centre Research Institute of South Africa), David Sokolov(Fred Hutch Cancer Center), I. Engström(Fred Hutch Cancer Center), Paul D. Lampe(University of Washington)
Science Translational Medicine
May 15, 2024
Cited by 15


Related Papers